Recombinant human granulocyte-macrophage colony stimulating factor (rhGM-CSF) reduces infection-related mortality after allogeneic T-cell depleted BMT. [electronic resource]
Producer: 19910927Description: 83 p. digitalISSN:- 0268-3369
- Bone Marrow Transplantation -- adverse effects
- Double-Blind Method
- Europe -- epidemiology
- Graft Survival -- drug effects
- Granulocyte-Macrophage Colony-Stimulating Factor -- pharmacology
- Hematopoiesis -- drug effects
- Humans
- Immunologic Factors -- pharmacology
- Infection Control
- Infections -- etiology
- Leukocyte Count -- drug effects
- Lymphocyte Depletion
- Neutropenia -- complications
- Prospective Studies
- Recombinant Proteins -- pharmacology
- T-Lymphocytes -- immunology
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.